Abnormal thyroid function tests in children on ethionamide treatment
dc.contributor.author | Thee S. | |
dc.contributor.author | Zollner E.W. | |
dc.contributor.author | Willemse M. | |
dc.contributor.author | Hesseling A.C. | |
dc.contributor.author | Magdorf K. | |
dc.contributor.author | Schaaf H.S. | |
dc.date.accessioned | 2011-10-13T16:58:14Z | |
dc.date.available | 2011-10-13T16:58:14Z | |
dc.date.issued | 2011 | |
dc.description.abstract | Ethionamide (ETH) treatment may cause hypothyroidism. Clinical data, serum thyroid stimulating hormone (TSH) and free thyroxine (fT4) levels were retrospectively assessed in 137 children receiving anti-tuberculosis treatment including ETH. Abnormal thyroid function tests (TFTs) were recorded in 79 (58%) children: elevated serum TSH and suppressed fT4 (n = 30), isolated elevated serum TSH (n = 20), isolated low serum fT4 (n = 28) and isolated low TSH (n = 1). The risk for biochemical hypothyroidism was higher for children on regimens including para-aminosalicylic acid and in human immunodefi ciency virus infected children. TFT abnormalities are frequent in children on ETH and are mainly due to primary hypothyroidism or euthyroid sick syndrome. © 2011 The Union. | |
dc.description.version | Article | |
dc.identifier.citation | International Journal of Tuberculosis and Lung Disease | |
dc.identifier.citation | 15 | |
dc.identifier.citation | 9 | |
dc.identifier.citation | http://www.scopus.com/inward/record.url?eid=2-s2.0-80051677011&partnerID=40&md5=a953a22a34c04b77b76745e7004842bc | |
dc.identifier.issn | 10273719 | |
dc.identifier.other | 10.5588/ijtld.10.0707 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/16655 | |
dc.subject | Children | |
dc.subject | Ethionamide | |
dc.subject | Thyroid function | |
dc.subject | Tuberculosis | |
dc.subject | aminosalicylic acid | |
dc.subject | ethionamide | |
dc.subject | thyrotropin | |
dc.subject | thyroxine | |
dc.subject | adolescent | |
dc.subject | article | |
dc.subject | biochemistry | |
dc.subject | child | |
dc.subject | controlled study | |
dc.subject | drug effect | |
dc.subject | extrapulmonary tuberculosis | |
dc.subject | female | |
dc.subject | human | |
dc.subject | Human immunodeficiency virus infection | |
dc.subject | hypothyroidism | |
dc.subject | infant | |
dc.subject | lung tuberculosis | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | preschool child | |
dc.subject | priority journal | |
dc.subject | risk assessment | |
dc.subject | side effect | |
dc.subject | thyroid function test | |
dc.subject | thyrotropin blood level | |
dc.subject | thyroxine blood level | |
dc.subject | tuberculous lymphadenitis | |
dc.subject | tuberculous meningitis | |
dc.title | Abnormal thyroid function tests in children on ethionamide treatment | |
dc.type | Article |